Apothecary series

🇹🇷 Bu sayfayı Türkçe oku MYCOVITA Apothecary Series — the scientific and transparent face of functional mushroom production. Every species is cultivated in a dedicated grow room, using Netherlands-certified genetic lines, low-temperature drying at 42–45 °C, and independent Certificate of Analysis (COA) testing for every batch.

Series Philosophy

The Apothecary Series brings together five species that hold the strongest scientific foundations in the functional mushroom literature. These species were not selected at random. Each one anchors a distinct family of bioactive compounds in the Turkish-language body of knowledge: Lion’s Mane stands for NGF synthesis, Reishi represents triterpenes, Cordyceps embodies cordycepin, Turkey Tail carries the PSK polysaccharide-protein complex, and Sparassis delivers high-purity β-1,3-glucan.

The Apothecary Series makes no medical claims. Products are manufactured and sold as foods within the framework of the Turkish Food Codex. All scientific content, together with its references, is presented in the Mycelium Library.

The Five Species

Lion’s Mane — Hericium erinaceus

Central to the neurotrophic literature. The hericenone and erinacine fractions are characterized by in vitro stimulation of NGF synthesis. Production: independent climate-controlled room, low CO₂, stepped humidity profile. Visit the encyclopedia for full species details.

Reishi Antler (Black Antler) — Ganoderma lucidum

The antler form is a morphological variant induced under high CO₂ conditions. It exhibits a markedly higher triterpene concentration compared to the classical conk form. The ganoderic acid series is the molecular source of the mushroom’s characteristic bitter taste. A detailed profile is available in the encyclopedia.

Sparassis — Sparassis crispa

Among naturally occurring edible mushrooms, Sparassis holds the highest β-1,3-glucan density. Its cauliflower-like morphology earns it the name Hanabiratake (flower mushroom). Cultivation is traditionally among the most challenging of any species. Explore the encyclopedia for an in-depth profile.

Cordyceps — Cordyceps militaris

Cordycepin — 3′-deoxyadenosine — is the signature compound of this species and is studied in the mitochondrial ATP synthesis literature. MYCOVITA uses the C. militaris strain, not the tropical C. sinensis. Access the species profile through the encyclopedia.

Turkey Tail — Trametes versicolor

The species that produces PSK (polysaccharide-K, Krestin) and PSP (polysaccharopeptide) — protein-bound β-glucan complexes. In Japan, PSK has been approved as an oncology adjuvant since 1977. Full species details are in the encyclopedia.

Production Standard

Every Apothecary species is manufactured under the following protocol:

• Netherlands-certified spawn with verified genetic identity.
• Species-specific substrate formulation, sterilized by autoclave.
• Five independent grow rooms — temperature, humidity, and CO₂ parameters tailored to each species.
• VRF climate control with ±0.5 °C precision.
• Post-harvest low-temperature drying at 42–45 °C to preserve enzyme structure.
• Every batch undergoes independent laboratory testing: ICP-MS for heavy metals, HPLC-MS for mycotoxins, and β-glucan analysis via the Megazyme AOAC 2009.02 method.
• 100% fruiting body — no substrate-borne mycelium powder.

Further detail: Production Process · Why MYCOVITA · Analysis Reports

In-Depth Reading

Additional content on this series — molecular cards, 30-day usage profiles, safety assessments, combination protocols, and comparative guides — is systematically organized in the Mycelium Library.

→ Reading Map — the library’s structured discovery tool. Use the species filters or category tabs to reach relevant content.

Legal Notice

MYCOVITA Apothecary products are classified as foods under the legislation of the Ministry of Agriculture and Forestry of the Republic of Türkiye. They are not intended for the treatment, prevention, or cure of any disease. Individuals taking chronic medication, pregnant and breastfeeding women, and children are advised to consult a physician before use.

Full legal framework: Legal Framework.

Version: 1.0  |  Last updated: 19 Apr 2026  |  Method: Editorial Policy